Compare SFM & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SFM | ACLX |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 6.7B |
| IPO Year | 2013 | 2022 |
| Metric | SFM | ACLX |
|---|---|---|
| Price | $71.43 | $115.07 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 15 |
| Target Price | $98.89 | ★ $115.85 |
| AVG Volume (30 Days) | ★ 1.6M | 783.3K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.60 | N/A |
| EPS | ★ 5.31 | N/A |
| Revenue | ★ $8,806,159,000.00 | $22,286,000.00 |
| Revenue This Year | $8.95 | $342.39 |
| Revenue Next Year | $7.36 | $170.71 |
| P/E Ratio | $13.77 | ★ N/A |
| Revenue Growth | ★ 14.08 | N/A |
| 52 Week Low | $64.75 | $47.86 |
| 52 Week High | $182.00 | $115.13 |
| Indicator | SFM | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 37.13 | 80.04 |
| Support Level | $64.88 | $63.46 |
| Resistance Level | $81.68 | N/A |
| Average True Range (ATR) | 2.64 | 0.10 |
| MACD | -0.43 | -0.62 |
| Stochastic Oscillator | 14.22 | 94.60 |
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.